Kiffer G Card1,2, Heather L Armstrong1,3, Nathan J Lachowsky1,4,5, Zishan Cui1, Paul Sereda1, Allison Carter1,2, Julio S G Montaner1,3, Robert S Hogg1,2, Eric A Roth5,6, David M Moore1,3. 1. British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. 2. Faculty of Health Science, Simon Fraser University, Vancouver, BC, Canada. 3. Department of Medicine, University of British Columbia, Vancouver, BC, Canada. 4. School of Public Health and Social Policy, University of Victoria, Victoria, BC, Canada. 5. Centre for Addiction Research of British Columbia, University of Victoria, Victoria, BC, Canada. 6. Department of Anthropology, University of Victoria, Victoria, BC, Canada.
Abstract
BACKGROUND: We evaluated attitudes toward treatment as prevention (TasP) among gay, bisexual, and other men who have sex with men (GBM) in Vancouver, Canada. METHODS: Sexually active GBM, aged ≥16 years, were recruited between 2012 and 2015 using respondent-driven sampling. At each 6-month follow-up, participants completed a computer-administered questionnaire and nursing visit. Repeated-measures latent class analysis, grouped by self-reported serostatus, identified patterns of TasP endorsement by considering TasP-related awareness, attitudes, and behavior. Binary logistic regression identified covariates of class membership. Bivariate interactions with visit number identified factors associated with longitudinal changes in class membership. RESULTS: A total of 774 men provided 2590 observations. Of these, 698 enrolled in the cohort, 575 had at least 1 follow-up visit. Among these, the median follow-up time was 1.98 years (Q1-Q2: 1.49-2.49 years). Repeated-measures latent class analysis identified 3 classes: "unaware" (64.2% HIV negative/unknown vs. 29.2% of HIV positive), "skeptical" (29.7% vs. 23.1%), and "believing" (6.1% vs. 47.7%). Membership in classes representing higher TasP endorsement was associated with greater odds of condomless anal sex and having more sexual partners. Age, sexual orientation, ethnicity, substance use, and social time spent with other GBM were also associated with class membership. Longitudinally, class membership was stable among HIV-positive men but shifted toward greater TasP endorsement among HIV-negative/unknown men. For HIV-negative/unknown men, increasing endorsement was positively associated with greater education, being employed, being in a relationship, and substance use and inversely associated with recent serodiscordant condomless anal sex or sexually transmitted infection diagnosis. CONCLUSIONS: Over time, disparities in TasP diffusion by HIV status have lessened, although continue to persist across other key social strata.
BACKGROUND: We evaluated attitudes toward treatment as prevention (TasP) among gay, bisexual, and other men who have sex with men (GBM) in Vancouver, Canada. METHODS: Sexually active GBM, aged ≥16 years, were recruited between 2012 and 2015 using respondent-driven sampling. At each 6-month follow-up, participants completed a computer-administered questionnaire and nursing visit. Repeated-measures latent class analysis, grouped by self-reported serostatus, identified patterns of TasP endorsement by considering TasP-related awareness, attitudes, and behavior. Binary logistic regression identified covariates of class membership. Bivariate interactions with visit number identified factors associated with longitudinal changes in class membership. RESULTS: A total of 774 men provided 2590 observations. Of these, 698 enrolled in the cohort, 575 had at least 1 follow-up visit. Among these, the median follow-up time was 1.98 years (Q1-Q2: 1.49-2.49 years). Repeated-measures latent class analysis identified 3 classes: "unaware" (64.2% HIV negative/unknown vs. 29.2% of HIV positive), "skeptical" (29.7% vs. 23.1%), and "believing" (6.1% vs. 47.7%). Membership in classes representing higher TasP endorsement was associated with greater odds of condomless anal sex and having more sexual partners. Age, sexual orientation, ethnicity, substance use, and social time spent with other GBM were also associated with class membership. Longitudinally, class membership was stable among HIV-positive men but shifted toward greater TasP endorsement among HIV-negative/unknown men. For HIV-negative/unknown men, increasing endorsement was positively associated with greater education, being employed, being in a relationship, and substance use and inversely associated with recent serodiscordant condomless anal sex or sexually transmitted infection diagnosis. CONCLUSIONS: Over time, disparities in TasP diffusion by HIV status have lessened, although continue to persist across other key social strata.
Authors: Susan M Graham; Sarah E Holte; Norbert M Peshu; Barbra A Richardson; Dana D Panteleeff; Walter G Jaoko; Jeckoniah O Ndinya-Achola; Kishorchandra N Mandaliya; Julie M Overbaugh; R Scott McClelland Journal: AIDS Date: 2007-02-19 Impact factor: 4.177
Authors: F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245
Authors: Rachel King; David Katuntu; Julie Lifshay; Laura Packel; Richard Batamwita; Sylvia Nakayiwa; Betty Abang; Frances Babirye; Pille Lindkvist; Eva Johansson; Jonathan Mermin; Rebecca Bunnell Journal: AIDS Behav Date: 2007-09-08
Authors: Kiffer G Card; Nathan J Lachowsky; Zishan Cui; Paul Sereda; Ashleigh Rich; Jody Jollimore; Terry Howard; Robert Birch; Allison Carter; Julio Montaner; David Moore; Robert S Hogg; Eric Abella Roth Journal: AIDS Behav Date: 2017-05
Authors: Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren Journal: JAMA Date: 2016-07-12 Impact factor: 56.272
Authors: Nathan John Lachowsky; Allan Lal; Jamie I Forrest; Kiffer George Card; Zishan Cui; Paul Sereda; Ashleigh Rich; Henry Fisher Raymond; Eric A Roth; David M Moore; Robert S Hogg Journal: J Med Internet Res Date: 2016-03-15 Impact factor: 5.428
Authors: Kiffer G Card; Heather L Armstrong; Lu Wang; Nicanor Bacani; David M Moore; Eric A Roth; Robert S Hogg; Nathan J Lachowsky Journal: AIDS Care Date: 2019-12-18
Authors: H Jonathon Rendina; Ali J Talan; Jorge Cienfuegos-Szalay; Joseph A Carter; Ore Shalhav Journal: AIDS Patient Care STDS Date: 2020-10 Impact factor: 5.078
Authors: Kevin M Maloney; David Benkeser; Patrick S Sullivan; Colleen Kelley; Travis Sanchez; Samuel M Jenness Journal: Epidemiology Date: 2022-07-27 Impact factor: 4.860
Authors: Kenneth H Mayer; Dorina Onoya; Jacob Bor; Charlie Fischer; Mirva Modi; Bruce Richman; Cameron Kinker; Rachel King; Sarah K Calabrese; Idah Mokhele; Tembeka Sineke; Thembelihle Zuma; Sydney Rosen; Till Bärnighausen Journal: AIDS Behav Date: 2021-05-25
Authors: H Jonathon Rendina; Jorge Cienfuegos-Szalay; Ali Talan; Stephen Scott Jones; Ruben H Jimenez Journal: J Acquir Immune Defic Syndr Date: 2020-03-01 Impact factor: 3.771
Authors: Orlando da Costa Ferreira-Júnior; Mark Drew Crosland Guimarães; Giseli Nogueira Damacena; Wanessa da Silva de Almeida; Paulo Roberto Borges de Souza-Júnior; Célia Landmann Szwarcwald Journal: Medicine (Baltimore) Date: 2018-05 Impact factor: 1.889
Authors: Thiago S Torres; Joseph Cox; Luana Ms Marins; Daniel Rb Bezerra; Valdilea G Veloso; Beatriz Grinsztejn; Paula M Luz Journal: J Int AIDS Soc Date: 2020-11 Impact factor: 5.396